alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31-1



Certification

I, James P. Laurito, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Rochester Gas and Electric Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

|Date:  November 4, 2004 | /s/James P. Laurito        James P. Laurito
        President
|----------------------- | -------------------------------------------------------------
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Small Business Administration [Disaster Declaration #16856 and #16857; Tennessee Disaster Number TN-00125]
 AGENCY: U.S. Small Business Administration.
 ACTION: Notice.
 SUMMARY: This is a notice of an Administrative declaration of a disaster for the State of Tennessee dated 01/28/2021. Incident: Explosion. Incident Period: 12/25/2020.
 DATES: Issued on 01/28/2021. *Physical Loan Application Deadline Date:*
                         03/29/2021. *Economic Injury (EIDL) Loan Application Deadline Date:*
                         10/28/2021.
 ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155.
 FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street SW, Suite 6050, Washington, DC 20416, (202) 205-6734.


SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the Administrator's disaster declaration, applications for disaster loans may be filed at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: *Primary Counties:*
                     Davidson. *Contiguous Counties:* Tennessee: Cheatham, Robertson, Rutherford, Sumner, Williamson, Wilson. *The Interest Rates are:* Percent*For Physical Damage:*Homeowners with Credit Available Elsewhere
2.250Homeowners without Credit Available Elsewhere
1.125Businesses with Credit Available Elsewhere
6.000Businesses without Credit Available Elsewhere
3.000Non-Profit Organizations with Credit Available Elsewhere
2.000Non-Profit Organizations without Credit Available Elsewhere
2.000*For Economic Injury:*Businesses & Small Agricultural Cooperatives without Credit Available Elsewhere
3.000Non-Profit Organizations without Credit Available Elsewhere
2.000
 The number assigned to this disaster for physical damage is 16856 4 and for economic injury is 16857 0. The State which received an EIDL Declaration # is Tennessee. (Catalog of Federal Domestic Assistance Number 59008) Tami Perriello, Acting Administrator.


[FR Doc. 2021-02214 Filed 2-2-21; 8:45 am] BILLING CODE 8026-03-P
Cómo detectar una estafa...

Decir que un producto es “natural”

no significa que es seguro.

No crea en promesas como “pierda

peso mientras duerme”. Si parece

demasiado fácil, puede ser una

estafa.

Se llama fraude a la salud

• Muchas personas se dejan engañar y compran productos de salud que 

 parecen excelentes, pero que en realidad son falsos. 

• Algunos productos pueden ocasionar problemas graves como dolor, 

 sufrimiento, o hasta la muerte.

• Es posible que la combinación de algunos de esos productos con otros 

 medicamentos que está tomando, sea nociva para su salud. 

• Además, puede perder su dinero comprando productos fraudulentos 

 que no sirven.

Tenga cuidado con estos anuncios. Es posible que

sean estafas.

Es natural ¡Es tan fácil!
Por lo general, una misma

pastilla no trata ni cura muchas

enfermedades diferentes como

cáncer, diabetes, SIDA o artritis.

No se deje presionar para que

compre. Tómese el tiempo para

averiguar y conocer mejor el

producto.

ANTES

Pregúntele siempre a su médico,

enfermera o farmacéutico qué es

lo mejor para su salud.

Pague ahora y ahorre

¡Cura milagrosa!

Ellos no quieren que usted lo sepa

Es fácil inventar historias de

buenos resultados narradas por

“personas reales” o por médicos.

Me hizo efecto

¡DESPUES!  ́
PROTÉJASE Y PROTEJA A SU FAMILIA

•	 Hable con un médico, enfermera o farmacéutico o llame a la 

Administración de Alimentos y Medicamentos (FDA) al

1-888-463-6332, antes de usar cualquier producto de salud

•	 Infórmese acerca de los fraudes relacionados con la salud en:

www.fda.gov/healthfraud

•	 Informe sobre algún problema con un producto a la Administración

de Alimentos y Medicamentos (FDA) en www.fda.gov/medwatch

o al 1-800-332-1088

•	 Informe sobre la publicidad falsa a la Comisión Federal de Comercio (FTC)

en www.ftc.gov o al 1-877-382-4357

Fraudes a la salud... 

No arriesgue su salud ni su dinero.

Es posible que vea anuncios en la televisión o en Internet que le hacen 

muchas promesas acerca de un nuevo producto para la salud. Pero, 

usted no sabe si realmente la ayudará. Hasta puede hacerle daño.

Este folleto fue preparado por:

Esta información fue preparada mediante la colaboración entre la Oficina de

Salud de la Mujer y la Oficina de Cumplimiento de la Ley de la FDA.

www.fda.gov/womens

La Administración de Alimentos y Medicamentos (FDA) define el fraude 

relacionado con los productos para la salud como la promoción, publicidad, 

distribución o venta engañosa de un producto que se anuncia como 

eficaz para prevenir, diagnosticar, tratar, curar o aliviar una enfermedad 

o trastorno de salud, o que supuestamente tiene algún otro efecto 

beneficioso sobre la salud, pero cuya seguridad y eficacia para esos fines 

no se han comprobado científicamente.
#### The People of the State of New York ex rel. Morris Nusskern, Appellant, v. Harry A. La Burt, as Director of Creedmoor State Hospital, Respondent.

Motion by appellant for reargument denied. Beldock, P. J., Christ, Hill, Rabin and Hopkins, JJ., concur.
[Federal Register Volume 86, Number 24 (Monday, February 8, 2021)]
[Notices]
[Page 8651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02496]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Initial Review Group; Neurological Sciences and Disorders 
C Translational Neural, Brain, and Pain Relief Devices.
    Date: March 1-2, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Diana M. Cummings, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute of 
Neurological Disorders and Stroke, NIH, NSC, 6001 Executive Blvd., 
Suite 3208, Rockville, MD 20852, <a href="/cdn-cgi/l/email-protection#81e2f4ecece8efe6f2e5e8c1efe8efe5f2afefe8e9afe6eef7"><span class="__cf_email__" data-cfemail="a0c3d5cdcdc9cec7d3c4c9e0cec9cec4d38ecec9c88ec7cfd6">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: February 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-02496 Filed 2-5-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
434.004 Acquisition strategy. ( a ) The program manager will develop, in coordination with the Acquisition Executive or Major Information Technology Systems Executive, a written charter outlining the authority, responsibility, accountability, and budget for accomplishing the proposed objective.
( b ) The program manager will develop, subject to the approval of the Acquisition Executive or Major Information Technology Systems Executive, a project control system to schedule, monitor, and regularly report on all aspects of the project. The control system shall establish reporting periods and milestones consistent with the key decisions listed in paragraph 9 of A-109.
( c ) Upon initiation of the project, the program manager will report regularly to the Acquisition Executive or Major Information Technology Systems Executive.
( d ) Specific procedures and requirements for information technology systems are included in the USDA Information Technology Capital Planning and Investment Control Guide which can be accessed on the USDA OCIO Web site at *http://www.ocio.usda.gov .*
509.405-1 Continuation of current contracts. ( a ) When a contractor appears as a current exclusion in the System for Award Management (SAM), consider terminating a contract under any of the following circumstances: ( 1 ) Any circumstances giving rise to the debarment or suspension also constitute a default in the contractor's performance of the contract.
( 2 ) The contractor presents a significant risk to the Government in completing the contract.
( 3 ) The conduct that provides the cause of the suspension, proposed debarment, or debarment involved a GSA contract.
( b ) Before terminating a contract when a contractor appears as a current exclusion in the SAM, consider the following factors: ( 1 ) Seriousness of the cause for debarment or suspension.
( 2 ) Extent of contract performance.
( 3 ) Potential costs of termination and reprocurement.
( 4 ) Need for or urgency of the requirement, contract coverage, and the impact of delay for reprocurement.
( 5 ) Availability of other safeguards to protect the Government's interest until completion of the contract.
( 6 ) Availability of alternate competitive sources to meet the requirement (e.g., other multiple award contracts, readily available commercial products and commercial services.)
( c ) The responsibilities of the agency head under FAR 9.405-1 are delegated to the Senior Procurement Executive.
[74 FR 12732, Mar. 25, 2009, as amended at 81 FR 1532, Jan. 13, 2016; 86 FR 68442, Dec. 2, 2021]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Archives and Records Administration

          - [NARA-2021-017]

# AGENCY:

Information Security Oversight Office (ISOO), National Archives and Records Administration (NARA).

# ACTION:

Notice of Federal Advisory Committee meeting.

# SUMMARY:

We are announcing an upcoming meeting of the National Industrial Security Program Policy Advisory Committee (NISPPAC).

# DATES:

The meeting will be on April 14, 2021, from 10:00 a.m. to 1:00 p.m. EST.

# ADDRESSES:

The April 14, 2021, meeting will be a virtual meeting. See supplementary procedures below.

# FOR FURTHER INFORMATION CONTACT:

                        Heather Harris Pagán, ISOO Program Analyst, by telephone at 202.357.5351, or by email at                         *NISPPAC@nara.gov.*

# SUPPLEMENTARY INFORMATION:

This meeting is open to the public in accordance with the Federal Advisory Committee Act (5 U.S.C. app 2) and implementing regulations at 41 CFR 101-6. The Committee will discuss National Industrial Security Program policy matters.

                    Procedures: You must register in advance through the Event Services link                     *https://ems8.intellor.com?​do=​register&​t=​1&​p=​836856*                     if you wish to attend. NISPPAC members, ISOO employees, and speakers should send an email to                     *NISPPAC@nara.gov*                     for the appropriate registration information instead of registering with the above link. Contact us via email at                     *NISPPAC@nara.gov with any questions.*

Brian P. McLaughlin,

Acting Committee Management Officer.

[FR Doc. 2021-03002 Filed 2-12-21; 8:45 am]

BILLING CODE 7515-01-P
# C_2021256EN.01000301.xml

| 30.6.2021 | EN | Official Journal of the European Union | C 256/3 |
| --- | --- | --- | --- |

30.6.2021

EN

Official Journal of the European Union

C 256/3

---

Euro exchange rates (1)

29 June 2021

(2021/C 256/03)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1888 |
| JPY | Japanese yen | 131,54 |
| DKK | Danish krone | 7,4363 |
| GBP | Pound sterling | 0,85948 |
| SEK | Swedish krona | 10,1510 |
| CHF | Swiss franc | 1,0965 |
| ISK | Iceland króna | 147,30 |
| NOK | Norwegian krone | 10,1893 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,477 |
| HUF | Hungarian forint | 351,11 |
| PLN | Polish zloty | 4,5193 |
| RON | Romanian leu | 4,9275 |
| TRY | Turkish lira | 10,3610 |
| AUD | Australian dollar | 1,5811 |
| CAD | Canadian dollar | 1,4706 |
| HKD | Hong Kong dollar | 9,2297 |
| NZD | New Zealand dollar | 1,7000 |
| SGD | Singapore dollar | 1,5985 |
| KRW | South Korean won | 1 341,25 |
| ZAR | South African rand | 17,0520 |
| CNY | Chinese yuan renminbi | 7,6814 |
| HRK | Croatian kuna | 7,4960 |
| IDR | Indonesian rupiah | 17 339,93 |
| MYR | Malaysian ringgit | 4,9353 |
| PHP | Philippine peso | 57,765 |
| RUB | Russian rouble | 86,4662 |
| THB | Thai baht | 38,166 |
| BRL | Brazilian real | 5,8826 |
| MXN | Mexican peso | 23,6108 |
| INR | Indian rupee | 88,3050 |

Currency

Exchange rate

USD

US dollar

1,1888

JPY

Japanese yen

131,54

DKK

Danish krone

7,4363

GBP

Pound sterling

0,85948

SEK

Swedish krona

10,1510

CHF

Swiss franc

1,0965

ISK

Iceland króna

147,30

NOK

Norwegian krone

10,1893

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,477

HUF

Hungarian forint

351,11

PLN

Polish zloty

4,5193

RON

Romanian leu

4,9275

TRY

Turkish lira

10,3610

AUD

Australian dollar

1,5811

CAD

Canadian dollar

1,4706

HKD

Hong Kong dollar

9,2297

NZD

New Zealand dollar

1,7000

SGD

Singapore dollar

1,5985

KRW

South Korean won

1 341,25

ZAR

South African rand

17,0520

CNY

Chinese yuan renminbi

7,6814

HRK

Croatian kuna

7,4960

IDR

Indonesian rupiah

17 339,93

MYR

Malaysian ringgit

4,9353

PHP

Philippine peso

57,765

RUB

Russian rouble

86,4662

THB

Thai baht

38,166

BRL

Brazilian real

5,8826

MXN

Mexican peso

23,6108

INR

Indian rupee

88,3050

---

(1)  Source: reference exchange rate published by the ECB.

---
Performance Reports

If you receive for a grant under this competition, you must ensure that you have in place the necessary processes and systems to comply with the reporting requirements in 2 CFR part 170 should you receive funding under the competition.  This does not apply if you have an exception under 2 CFR 170.110(b). 

At the end of your project period, you must submit a final performance report, including financial information, as directed by the Secretary.  If you receive a multiyear award, you must submit an annual performance report that provides the most current performance and financial expenditure information as directed by the Secretary under 34 CFR 75.118.  The Secretary may also require more frequent performance reports under 34 CFR 75.720(c). For specific requirements on reporting, please go to www.ed.gov/fund/grant/apply/appforms/appforms.html.

Performance Measures

For the purpose of Department reporting under 34 CFR 75.110, the Department has established a set of required performance measures (as defined in this notice): 
- First-year credit accumulation. 
- Annual retention (at initial institution) and persistence (at any institution) rates. 
- Success rates including graduation and upward transfer for two-year institutions. 
- Time to credential. 
- Number of credentials conferred. 

All measures should be disaggregated by race/ethnicity and Pell grant recipient status and should be inclusive of all credential-seeking students (e.g., full-time and part-time, first-time and transfer-in.)
Project-Specific Performance Measures
Applicants must propose project-specific performance measures and performance targets (both as defined in this notice) consistent with the objectives of the proposed project. 

Applications must provide the following information as directed under 34 CFR 75.110(b): 
- Performance measures.  How each proposed performance measure would accurately measure the performance of the project and how the proposed performance measure would be consistent with the performance measures established for the program funding the competition. 
- Baseline (as defined in the NIA) data.  (i) Why each proposed baseline is valid; or (ii) if the applicant has determined that there are no established baseline data for a particular performance measure, an explanation of why there is no established baseline and of how and when, during the project period, the applicant would establish a valid baseline for the performance measure. 
- Performance targets.  Why each proposed performance target is ambitious yet achievable compared to the baseline for the performance measure and when, during the project period, the applicant would meet the performance target(s). 

FIPSE Home
  Last Modified: 07/27/2023
- Skip to main content
- About Us
- Contact Us
- FAQs
-  Language Assistance ****   - English
  - español
  - 中文: 繁體版
  - Việt-ngữ
  - 한국어
  - Tagalog
  - Русский

U.S. Department of Education

U.S. Department of Education

            - Student Loans
            - Grants
            - Laws
            - Data

TeachersIMPROVE STUDENT PERFORMANCE 
| Editor's Picks                                                                |
|------------------------------------------------------------------------------------|
|                                                                                    |
|                                                                                    | |							 1 |							2 |							3 |							4 |							5 | |  |
|                                                                                    |
| 1 - 10 of 52 Shown			Articles per page  				10 | 				25  | 				50 |